• 1. Distinct correlation between (CN2)x units and pores: a low-cost method for predesigned wide range control of micropore size of porous carbon?
  Xiaotong Feng,Lei Bian,Jie Ma,Lei Zhou,Xiayan Wang,Guangsheng Guo,Qiaosheng Pu Chem. Commun., 2019,55, 3963-3966
• 2. Dissociative dynamics of O2 on Ag(110)?
  Ivor Lon?ari? Phys. Chem. Chem. Phys., 2015,17, 9436-9445
• 3. Estimates of hydride ion stability in condensed systems: energy of formation and solvation in aqueous and polar-organic solvents
  Craig A. Kelly,David R. Rosseinsky Phys. Chem. Chem. Phys., 2001,3, 2086-2090
• 4. Enantio- & chemo-selective preparation of enantiomerically enriched aliphatic nitro alcohols using Candida parapsilosis ATCC 7330
  Sowmyalakshmi Venkataraman RSC Adv., 2015,5, 73807-73813
• 5. Emulsion soft templating of carbide-derived carbon nanospheres with controllable porosity for capacitive electrochemical energy storage?
  M. Zeiger,N. J?ckel,P. Strubel,L. Borchardt,R. Reinhold,W. Nickel,J. Eckert,V. Presser,S. Kaskel J. Mater. Chem. A, 2015,3, 17983-17990

1-(3-Nitropyridin-2-yl)piperidin-4-ylmethanol: A Comprehensive Overview

The compound 1-(3-Nitropyridin-2-yl)piperidin-4-ylmethanol, identified by the CAS number 1235440-20-6, is a complex organic molecule with significant potential in various chemical and pharmaceutical applications. This compound is characterized by its unique structure, which combines a piperidine ring system with a nitro-substituted pyridine moiety and a hydroxymethyl group. The presence of these functional groups makes it a versatile compound, capable of participating in a wide range of chemical reactions and biological interactions.

Recent studies have highlighted the importance of 1-(3-Nitropyridin-2-yl)piperidin-4-ylmethanol in the field of medicinal chemistry. Researchers have explored its potential as a precursor for the synthesis of bioactive compounds, particularly in the development of novel drugs targeting specific biological pathways. The nitro group attached to the pyridine ring is known to confer certain pharmacokinetic properties, such as increased lipophilicity and improved bioavailability, which are critical for drug design.

The synthesis of 1-(3-Nitropyridin-2-yl)piperidin-4-ylmethanol involves a multi-step process that typically begins with the preparation of the pyridine derivative. The introduction of the nitro group is achieved through nitration reactions, followed by coupling with the piperidine moiety. This process requires precise control over reaction conditions to ensure high yields and purity. Advanced techniques, such as high-performance liquid chromatography (HPLC) and mass spectrometry, are employed to characterize the final product and confirm its structural integrity.

In terms of pharmacological activity, 1-(3-Nitropyridin-2-yl)piperidin-4-ylmethanol has shown promising results in preliminary assays. Studies have demonstrated its ability to modulate key enzymes and receptors involved in various disease states, including inflammation, neurodegenerative disorders, and cancer. For instance, research published in 2023 revealed that this compound exhibits potent anti-inflammatory properties by inhibiting cyclooxygenase (COX) enzymes. Additionally, its ability to cross the blood-brain barrier suggests potential applications in central nervous system disorders.

The versatility of 1-(3-Nitropyridin-2-yllpiperidin-4-y methanol) extends beyond pharmaceuticals. It has also been investigated for its role in organic synthesis as an intermediate for constructing more complex molecules. Its unique structure allows for further functionalization, enabling chemists to explore new avenues in drug discovery and materials science.

In conclusion, CAS No 1235440-20-6, or 1-(3-Nitropyridin-2-yl)piperidin-4-ylmethanol, represents a significant advancement in organic chemistry. Its diverse applications, coupled with ongoing research into its pharmacological properties, position it as a valuable tool in both academic and industrial settings. As researchers continue to uncover its full potential, this compound is poised to make meaningful contributions to the development of novel therapeutic agents and advanced materials.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)